Overview

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Atomoxetine versus placebo in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride